Prof Georgina V Long AO, BSc (Hons1, UM) PhD, MBBS (Hons), FRACP, FAHMS, FAA, FASCO, is Medical Director at Melanoma Institute Australia (MIA) and Chair of Melanoma Medical Oncology and Translational Research at MIA and Royal North Shore Hospital, The University of Sydney. Long is a world-leading medical oncologist and researcher, focusing on response and resistance immuno-oncology and targeted therapies, and the development of novel immunotherapies in cancer.

Prof Long leads the Cancer Translational Research Group at the Charles Perkins Centre, The University of Sydney, which comprises 30 researchers and support staff. Long is Chief Investigator on NHMRC-funded research into the molecular biology of melanoma and clinical and tissue biomarker correlates of systemic therapy sensitivity and resistance. Prof Long’s translational research is linked to her extensive clinical trials platform at MIA, which that includes investigator-led and industry research high-risk and advanced melanoma, including active brain metastases.

Prof Long was named 2024 Australian of the Year and was awarded prestigious Fellowships with the American Society for Clinical Oncology (2025), the Australian Academy of Science (2024), and the Australian Academy of Health and Medical Sciences (2017), the latter awarding her the Outstanding Female Research Medal (2021). Long was appointed as an Officer of the Order of Australia (2020). Other awards include the Fulbright US Mission Australia Award for Leadership Excellence (2024), Estela Medrano Melanoma Award (2024), ESMO Women for Oncology Award (2023), SLHD 2022 Research Excellence Award (2022), and the prestigious Ramaciotti Medal for Biomedical Research (2021). She has a number of CINSW Premier’s Awards, including; the Outstanding Cancer Researcher (2018), the Excellence in Translational Cancer Research Award (2017), the Wildfire Award for the most highly cited, original, annual peer-reviewed article (2011, 2014, 2016, & 2017–2020), and in 2013 she was named the Outstanding Cancer Research Fellow.

Prof Long is the author of over 610 peer-reviewed publications in clinical and translational research in melanoma, including Nature, Science,  Lancet, Cancer Cell, Nat Med, Cancer Disc, and N Engl J Med. Long has presented her work at international conferences and meetings on more than 300 occasions. She is a Clarivate Highly Cited Researcher (2017–) with an H-index of 156.